Rejuvenate Bio

Founded in 1998, Althea Technologies is one of the leading providers of contract services for the pharmaceutical and biotechnology industries worldwide. It offers a range of clinical and commercial manufacturing and testing services. The company provides process development, stability testing, regulatory support, protein engineering and plasmid production services. Althea Technologies testing services include clinical sample analysis, custom assay development, host cell DNA contamination and integration studies. It operates WindRose Analytica, which specializes in the development of biopharmaceutical products. The company s subsidiary, AltheaDx, offers clinical trial and predictive drug response services. Althea Technologies maintains a more than 30,000-square-foot clinical manufacturing facility.

Verogen, Inc., a San Diego-based company, has recently been acquired by QIAGEN, a global leader in Sample to Insight solutions for molecular testing. Verogen specializes in providing innovative products and services for human identification, offering a range of DNA sequencing kits, analysis software, and support resources for forensic and investigative genetic genealogy applications. With a focus on STRs, mitochondrial DNA, and externally visible characteristics, Verogen's products enable accurate and efficient DNA analysis. Their comprehensive offerings, including the ForenSeq DNA Signature Prep Kit and MiSeq FGx Sequencing System, empower law enforcement agencies and researchers to unlock the potential of next-generation sequencing technology in human identification. As part of QIAGEN, Verogen continues to advance the field of forensic genetics while upholding corporate social responsibility and sustainability.Generated from the website

Nielsen Biosciences, Inc. is a privately held biopharmaceutical company based in San Diego, California, dedicated to developing and commercializing biological products that leverage cell-mediated immune responses. The company is actively engaged in clinical trials, including a Phase 3 study evaluating CANDIN for the treatment of human papillomavirus (HPV) conditions such as common warts. In addition to CANDIN, Nielsen Biosciences offers Spherusol, a skin test antigen for detecting delayed-type hypersensitivity to Coccidioides immitis, the causative agent of Valley Fever. Both products are designed to assess and monitor immune responses, contributing to advancements in immunotherapy and patient care. Generated from the website